Comparison of the two muscular dystrophy phenotypes, DMD and BMD, in the UNEW cohort revealed again CA3 as an important contributor for the separation of these two patient groups (Fig 2C and D) and MDH2 and MYL3 for separation of the BMD patients and female carriers in both blood preparation types. The gene discussed is MYL3; the disease is Duchenne muscular dystrophy.